IP Library Granted Patent US 7,678,888
Granted Patent B2
US 7,678,888 · App. 10/593,387 · Granted Mar 16, 2010

Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof

Assignee: Albert Einstein College of Medicine of Yeshiva University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,678,888
App. No.
10/593,387
Granted
Mar 16, 2010
Kind
B2
Abstract

The present invention provides oxygenated hemoglobins in powdered form and methods of preparing a powdered form of a protein, such as hemoglobin, which comprise (a) mixing a solution of the protein with inulin, and optimally with a reducing sugar such as glucose or tagatose, and (b) drying the mixture. Also provided are blood substitutes formed from reconstituted powdered hemoglobins, and methods of treatment using the blood substitutes.

Claims (18)

1. A method of preparing a powdered form of a protein, which comprises:

(a) mixing a solution of the protein with inulin and tagatose, and

(b) drying the mixture.

2. The method of claim 1 , wherein the inulin is derived from Chicory Root.

3. The method of claim 1 , wherein the drying step comprises lyophilization.

4. The method of claim 1 , wherein the drying step comprises air drying.

5. The method of claim 4 , wherein the mixture is cooled as it is being air dried.

6. The method of claim 1 , wherein the protein is hemoglobin.

7. The method of claim 6 , wherein the hemoglobin is pegylated.

8. The method of claim 7 , wherein the pegylated hemoglobin comprises one or more polyethylene glycol (PEG) molecules with a molecular weight of 200-40,000 daltons.

9. The method of claim 8 , wherein the PEGs comprise a PEG with a molecular weight of 5,000 daltons.

10. The method of claim 7 , wherein the hemoglobin is pegylated with 2-8 PEGs.

11. The method of claim 7 , wherein the hemoglobin is pegylated with 2-4 PEGs.

12. The method of claim 6 , wherein the hemoglobin is oxygenated.

13. The method of claim 12 , wherein the hemoglobin is resistant to oxidation.

14. The method of claim 12 , wherein the hemoglobin is stable at room temperature.

15. The method of claim 12 , wherein the powdered hemoglobin contains no more than 20% of the met form of hemoglobin.

16. The method of claim 12 , wherein the powdered hemoglobin contains no more than 10% of the met form of hemoglobin.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 29, 2018
From: EINSTEIN COLLEGE OF MEDICINE, INC.
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047873/0703 →
CONFIRMATORY LICENSE Recorded Jun 4, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035828/0042 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: FRIEDMAN, JOEL M.; NAVATI, MAHANTESH S.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 019710/0628 →
Continuity (2)
Provisional Application 6056416600 · Apr 21, 2004
Related Publication 20080039370A1 · Feb 14, 2008